BRPI0822997A2 - Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use - Google Patents

Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use

Info

Publication number: BRPI0822997A2
Authority: BR; Brazil
Prior art keywords: immunomodulatory; extracts; manufacture; methods; lactobacillus bacteria
Prior art date: 2008-09-04

Application number

BRPI0822997-0A

Other languages

Portuguese (pt)

Inventor

Jacques Alain Bauer

Marco Salvagni

Jean-Pierre Leon Vigroux

Laetitia Leela Gisele Chalvet

Carlo Chiavaroli

Original Assignee

Om Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-09-04

Filing date

2008-09-04

Publication date

2015-06-23

2008-09-04 Application filed by Om Pharma filed Critical Om Pharma

2015-06-23 Publication of BRPI0822997A2 publication Critical patent/BRPI0822997A2/en

Links

241000186660 Lactobacillus Species 0.000 title 1
239000000284 extract Substances 0.000 title 1
230000002519 immonomodulatory effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0822997-0A 2008-09-04 2008-09-04 Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use BRPI0822997A2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/010350 WO2010027344A1 (en)	2008-09-04	2008-09-04	Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Publications (1)

Publication Number	Publication Date
BRPI0822997A2 true BRPI0822997A2 (en)	2015-06-23

Family

ID=41797341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0822997-0A BRPI0822997A2 (en)	2008-09-04	2008-09-04	Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use

Country Status (11)

Country	Link
JP (1)	JP2012502026A (en)
KR (1)	KR20110051268A (en)
CN (1)	CN102143756A (en)
AU (1)	AU2008361375B2 (en)
BR (1)	BRPI0822997A2 (en)
CA (1)	CA2733249A1 (en)
IL (1)	IL211041A0 (en)
MX (1)	MX2011002080A (en)
RU (1)	RU2500412C2 (en)
WO (1)	WO2010027344A1 (en)
ZA (1)	ZA201100899B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9770476B2 (en)	2011-02-02	2017-09-26	Justbio Inc.	Functional foods and beverages with synergistic properties to promote homeostasis
BR112013024831A2 (en) *	2011-03-29	2016-12-20	Nestec Sa	natural derivative of the cncm i-1225 strain of lactobacillus johnsonii, deficient in d = lactic acid production and with a higher immune profile
DK2697371T3 (en) *	2011-03-29	2016-12-12	Nestec Sa	LACTOBACILLUS STRAIN johnsonii CNCM I-4437, D-deficient in the production of lactic acid and having an improved shelf life
US20130022586A1 (en)	2011-07-21	2013-01-24	James Versalovic	Production and use of bacterial histamine
US12268718B2 (en)	2012-01-16	2025-04-08	Labyrinth Holdings Llc	Control of cellular redox levels
SG11201402650RA (en)	2012-01-16	2014-06-27	Elizabeth Mckenna	Compositions and methods for the treatment of hepatic diseases and disorders
BR112015006264A2 (en)	2012-09-21	2017-07-04	Mckenna Elizabeth	naturally occurring cpg oligonucleotide compositions and their therapeutic applications
US20150017208A1 (en) *	2013-07-12	2015-01-15	National Yang-Ming University	Lactic acid bacterium having immunomodulatory and anti-allergic effects
JP6491422B2 (en) *	2013-09-26	2019-03-27	雪印メグミルク株式会社	Immune disease preventive
JP6821643B2 (en) *	2013-09-26	2021-01-27	雪印メグミルク株式会社	Immune disease preventive agent
CN104957260B (en) *	2014-03-07	2018-07-24	内蒙古伊利实业集团股份有限公司	Have effects that alleviate the probiotic food composition and food of bottleneck throat inflammation
KR101627806B1 (en) *	2014-06-23	2016-06-07	한국식품연구원	The culturing method for increasing immune-enhancing activity in Lactobacillus spp.
JP6940305B2 (en) *	2017-06-01	2021-09-22	株式会社明治	How to make cheese flavored ingredients
KR102335710B1 (en)	2017-10-31	2021-12-07	(주)아모레퍼시픽	Immunomodulatory composition comprising extracellular vesicles derived from lactic acid bacteria
TWI731209B (en) *	2018-01-09	2021-06-21	柯順議	Probiotics composition and uses thereof
SG10202112104UA (en)	2018-05-09	2021-12-30	Ko Biolabs Inc	Lactobacillus paracasei strain and use thereof
US12220394B2 (en)	2018-06-07	2025-02-11	National University Corporation Kanazawa University	Pharmaceutical composition for prevention or treatment of kidney damage
US20210283082A1 (en) *	2018-06-07	2021-09-16	National University Corporation Kanazawa University	Pharmaceutical composition for prevention or treatment of kidney damage
CN109007842A (en) *	2018-10-29	2018-12-18	广州普维君健药业有限公司	Have effects that prevent and treat the probiotic composition of allergy and its application
KR102156829B1 (en) *	2019-02-22	2020-09-18	가톨릭대학교 산학협력단	Composition for preventing or treating immune diseases comprising mixture of Microbiome
CN109628359B (en) *	2019-02-22	2021-03-02	江南大学	A strain of Lactobacillus reuteri that can relieve allergic asthma and its application
BR112021018006A2 (en)	2019-03-14	2021-11-16	Om Pharma Sa	Pharmaceutical-stable bacterial extracts
CN110643541B (en) *	2019-10-25	2021-08-24	江南大学	A Lactobacillus casei that can regulate the balance of Th2/Th1 in allergic asthma and its application
CN111053789A (en) *	2019-11-26	2020-04-24	湖南营养树生物科技有限公司	Methods and compositions for modulating the immune system
US20230045151A1 (en) *	2020-01-13	2023-02-09	Monash University	Compositions and methods
CN111548961A (en) *	2020-05-15	2020-08-18	郑州和合生物工程技术有限公司	Probiotic composition for improving allergic diseases, probiotic composition powder, preparation method and application
US11826390B2 (en) *	2020-06-06	2023-11-28	Quorum Innovations, Llc	Materials and methods for inhibiting a viral infection, including a coronavirus infection
CN111991428A (en) *	2020-06-12	2020-11-27	郑州和合生物工程技术有限公司	Probiotic composition with asthma improving effect and preparation method thereof
CN112057479B (en) *	2020-11-16	2021-02-12	河北一然生物科技有限公司	Probiotic composition capable of relieving diarrhea caused by antibiotics
KR102424594B1 (en) *	2020-11-30	2022-07-25	파이토지노믹스 주식회사	Lactobacillus fermentum OKBL-L.FE 1 strain having anti-inflammatory activity and antimicrobial activity against pathogenic microorganism and uses thereof
JP7723917B2 (en) *	2021-05-11	2025-08-15	スノーデン株式会社	Method for producing toll-like receptor 2 binding substance
KR20230001127A (en)	2021-06-28	2023-01-04	농업회사법인 산청바이오진생마을 주식회사	Method for manufacturing ginseng sprout
WO2023167563A1 (en) *	2022-03-03	2023-09-07	한국생명공학연구원	Composition containing n-carbamyl-l-glutamic acid for treatment of inflammatory diseases
CN114774302B (en) *	2022-03-09	2023-06-16	善恩康生物科技（苏州）有限公司	Application of lactobacillus plantarum CQPC02 in preparation of product for preventing and/or treating lupus nephritis
WO2024065274A1 (en) *	2022-09-28	2024-04-04	Synbio Tech Inc.	Method against salmonella typhimurium infection with symbiotic composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH532903A (en) *	1971-06-25	1973-01-31	Nestle Sa	Process of extracting proteins from cells of microorganisms
JP3004890B2 (en) *	1995-03-28	2000-01-31	雪印乳業株式会社	Pathogen infection protective agent
EP1239032A1 (en) *	2001-03-02	2002-09-11	Société des Produits Nestlé S.A.	Lactic acid bacteria as agents for treating and preventing allergy
PE20030274A1 (en) *	2001-07-26	2003-05-08	Alimentary Health Ltd	LACTOBACILLUS SALIVARIUS STRAINS
RU2302458C2 (en) *	2001-07-26	2007-07-10	Элиментери Хелс Лимитед	Lactobacillus salivarius probiotic strain (variants), probiotic preparation based on the same, and method for treatment or prevention using lactobacillus salivarius strains
US7025998B2 (en) *	2003-05-30	2006-04-11	Rotta Research Laboratorium S.P.A.	Phytoestrogens and probiotic for women's health
EP1722804B1 (en) *	2004-03-04	2015-01-21	E-L Management Corp.	Skin treatment method with lactobacillus extract
ATE512211T1 (en) *	2005-05-31	2011-06-15	Iams Company	FELINE PROBIOTIC LACTOBACILLI
JP2007269737A (en) *	2006-03-31	2007-10-18	Morinaga Milk Ind Co Ltd	Interleukin production regulator, pharmaceutical composition and food / beverage products containing the interleukin production regulator, and method for producing the same
JP5019961B2 (en) *	2006-06-26	2012-09-05	株式会社ヤクルト本社	Interleukin 10 production promoter

2008
- 2008-09-04 CN CN2008801309602A patent/CN102143756A/en active Pending
- 2008-09-04 WO PCT/US2008/010350 patent/WO2010027344A1/en not_active Ceased
- 2008-09-04 CA CA2733249A patent/CA2733249A1/en not_active Abandoned
- 2008-09-04 JP JP2011526017A patent/JP2012502026A/en active Pending
- 2008-09-04 RU RU2011112781/15A patent/RU2500412C2/en not_active IP Right Cessation
- 2008-09-04 BR BRPI0822997-0A patent/BRPI0822997A2/en not_active IP Right Cessation
- 2008-09-04 MX MX2011002080A patent/MX2011002080A/en not_active Application Discontinuation
- 2008-09-04 KR KR1020117007527A patent/KR20110051268A/en not_active Ceased
- 2008-09-04 AU AU2008361375A patent/AU2008361375B2/en not_active Expired - Fee Related
2011
- 2011-02-03 ZA ZA2011/00899A patent/ZA201100899B/en unknown
- 2011-02-03 IL IL211041A patent/IL211041A0/en unknown

Also Published As

Publication number	Publication date
ZA201100899B (en)	2012-05-30
JP2012502026A (en)	2012-01-26
WO2010027344A1 (en)	2010-03-11
KR20110051268A (en)	2011-05-17
AU2008361375A1 (en)	2010-03-11
AU2008361375B2 (en)	2014-05-22
IL211041A0 (en)	2011-04-28
CA2733249A1 (en)	2010-03-11
MX2011002080A (en)	2011-03-29
RU2011112781A (en)	2012-10-10
CN102143756A (en)	2011-08-03
RU2500412C2 (en)	2013-12-10

Legal Events

Date	Code	Title	Description
2015-08-25	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 3A E 7A ANUIDADES.
2016-05-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0822997A2 (en)	2015-06-23	Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use
BRPI1014544A2 (en)	2016-04-05	anti-il-17f anticorpors and methods of use
BRPI1011384A2 (en)	2016-03-15	proproteins and their methods of use
BRPI0916269A2 (en)	2018-05-29	tissue modification device and its method of use
BRPI1011404A2 (en)	2016-03-15	mutants and their uses
BRPI0909077A2 (en)	2015-08-25	Multilayer articles and methods of preparation and use
BR112013013167A2 (en)	2017-10-31	bromodomain inhibitors and their uses
PT2424896E (en)	2015-11-30	ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE OF THE SAME
BRPI0922708A2 (en)	2018-11-06	minihepidine peptides and methods of use thereof
BRPI1012333A2 (en)	2016-03-29	atropisomers of 2-purinyl-3-tolyl-quinazolinones derivatives and methods of use
BRPI1010024A2 (en)	2019-09-24	aminopyrrolidinone derivatives and their use
BRPI1007175A2 (en)	2015-08-18	Mutant hydroxyphenylpriruvate dioxigenase polypeptides and methods of use
BRPI0909954A2 (en)	2015-11-03	"diazacarbazoles and methods of use"
EP2301812A4 (en)	2012-08-22	PARKING AIDS AND PARKING PROCEDURE
HUE036439T2 (en)	2018-07-30	Antimicrobials and methods of their application
BRPI1009847A2 (en)	2017-06-06	Medical connectors and methods of use
BR112012004375A2 (en)	2016-03-15	beach towel and beach towel method
BRPI0918693A2 (en)	2016-07-26	sampling devices and methods for the concentration of microorganisms
BRPI1013432A2 (en)	2016-04-05	indolizine derivative and use thereof for medical purposes
BRPI0924440A2 (en)	2016-01-26	bone restoration apparatus and methods of use
BRPI1005960A2 (en)	2019-09-24	implant system and use of an implant system
BRPI0913086A2 (en)	2015-08-04	Antimicrobial Compositions and Methods of Use
BRPI0907575A2 (en)	2015-07-21	Binding visual properties of charts and cells within tables
BR112014009837A2 (en)	2017-05-02	Effective use of yeast and yeast extract
SMT202000411T1 (en)	2020-09-10	Modified rsv f proteins and methods of their use